MASI - Masimo Corp Stock Price, Fair Value and News

120.02USD-15.98 (-11.75%)Market Closed

Market Summary

USD120.02-15.98

Market Closed

-11.75%

MASI Alerts

1 major insider sales recently.

Big fall in Revenue (Y/Y)

MASI Stock Price

View Fullscreen

MASI RSI Chart

MASI Valuation

Market Cap

6.4B

Price/Earnings (Trailing)

80.58

Price/Sales (Trailing)

3.23

EV/EBITDA

43.04

Price/Free Cashflow

66.53

MASI Price/Sales (Trailing)

MASI Profitability

EBT Margin

4.39%

Return on Equity

5.79%

Return on Assets

2.67%

Free Cashflow Yield

1.5%

MASI Fundamentals

MASI Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

-12.78%

Rev. Growth (Qtr)

-10.22%

MASI Earnings

Earnings (TTM)

79.1M

Earnings Growth (Yr)

-11.27%

Earnings Growth (Qtr)

-44.25%

Breaking Down MASI Revenue

Last 7 days

-10.4%

Last 30 days

-16.1%

Last 90 days

-12.1%

Trailing 12 Months

-34.8%

How does MASI drawdown profile look like?

MASI Financial Health

Current Ratio

2.31

Debt/Equity

0.62

Debt/Cashflow

0.17

MASI Investor Care

Shares Dilution (1Y)

0.54%

Diluted EPS (TTM)

1.47

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.0B	0	0	0
2023	2.3B	2.2B	2.1B	2.0B
2022	1.2B	1.5B	1.7B	2.0B
2021	1.2B	1.2B	1.2B	1.2B
2020	975.8M	1.0B	1.1B	1.1B
2019	877.0M	895.0M	913.5M	937.8M
2018	806.6M	825.9M	843.1M	858.3M
2017	720.1M	739.8M	765.5M	790.2M
2016	646.7M	663.7M	678.7M	694.6M
2015	601.4M	616.2M	624.6M	630.1M
2014	551.1M	554.6M	567.3M	586.6M
2013	509.9M	524.6M	537.0M	547.2M
2012	445.2M	458.4M	473.4M	493.2M
2011	419.7M	429.2M	432.2M	439.0M
2010	362.4M	378.9M	392.4M	405.4M
2009	0	321.1M	335.1M	349.1M
2008	0	0	0	307.1M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Masimo Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 01, 2024	reynolds craig b	acquired	230,400	23.04	10,000	-
Apr 26, 2024	reynolds craig b	acquired	921,600	23.04	40,000	-
Apr 26, 2024	reynolds craig b	sold	-5,446,620	136	-40,000	-
Feb 28, 2024	kiani joe e	acquired	-	-	10,050	ceo and chairman of the board
Feb 28, 2024	mcclenahan thomas samuel	sold (taxes)	-50,707	128	-394	evp, gen counsel & corp sec
Feb 28, 2024	mcclenahan thomas samuel	acquired	-	-	1,004	evp, gen counsel & corp sec
Feb 28, 2024	young micah w	sold (taxes)	-49,935	128	-388	evp & chief financial officer
Feb 28, 2024	young micah w	acquired	-	-	1,004	evp & chief financial officer
Feb 28, 2024	muhsin bilal	sold (taxes)	-95,881	128	-745	chief operating officer
Feb 28, 2024	muhsin bilal	acquired	-	-	2,010	chief operating officer

Which funds bought or sold MASI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Qsemble Capital Management, LP	new	-	244,946	244,946	0.05%
May 07, 2024	VERUS CAPITAL PARTNERS, LLC	reduced	-9.87	61,331	536,149	0.06%
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-20.99	-56,000	5,489,000	0.01%
May 07, 2024	M&T Bank Corp	added	3.36	82,340	360,904	-%
May 07, 2024	Smithfield Trust Co	unchanged	-	2,000	10,000	-%
May 07, 2024	Susquehanna Portfolio Strategies, LLC	reduced	-14.61	697,009	10,680,300	0.25%
May 07, 2024	KCM INVESTMENT ADVISORS LLC	reduced	-0.41	70,409	354,643	0.01%
May 07, 2024	Arizona State Retirement System	reduced	-1.65	341,613	1,812,720	0.01%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	reduced	-42.37	-866,052	2,249,740	-%
May 07, 2024	ASSETMARK, INC	added	11.85	38,903	135,836	-%

Are Funds Buying or Selling MASI?

Are funds buying MASI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MASI

No. of Funds

Unveiling Masimo Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 27, 2024	politan capital management lp	8.9%	4,713,518	SC 13D/A
Feb 14, 2024	kiani joe e	9.2%	4,972,819	SC 13G/A
Feb 13, 2024	vanguard group inc	9.05%	4,781,318	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 24, 2024	blackrock inc.	10.7%	5,659,131	SC 13G/A
Jun 30, 2023	politan capital management lp	8.9%	4,713,518	SC 13D/A
May 01, 2023	politan capital management lp	9.0%	4,713,518	SC 13D/A
Mar 13, 2023	politan capital management lp	9.0%	4,739,963	SC 13D/A
Mar 06, 2023	politan capital management lp	9.0%	4,739,963	SC 13D/A
Feb 14, 2023	kiani joe e	9.3%	4,975,021	SC 13G/A

Recent SEC filings of Masimo Corp

View All Filings

Date Filed	Form Type	Document
May 08, 2024	8-K	Current Report
May 08, 2024	SC 13D/A	13D - Major Acquisition
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
May 03, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 29, 2024	10-K/A	Annual Report
Apr 26, 2024	144	Notice of Insider Sale Intent
Apr 02, 2024	DEFA14A	DEFA14A
Apr 01, 2024	DEFA14A	DEFA14A

Peers (Alternatives to Masimo Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.6B	40.3B	-5.05%	-4.82%	32.45	4.53	-2.84%	-3.08%
BDX	67.4B	19.7B	-3.45%	-6.52%	50.6	3.42	4.82%	-17.56%
ALGN	20.6B	3.9B	-14.54%	-9.65%	44.54	5.26	5.72%	46.72%
BAX	18.2B	14.9B	-15.38%	-17.01%	6.88	1.22	2.98%	207.68%
MID-CAP
ATR	10.0B	3.5B	7.32%	25.05%	31.94	2.82	6.16%	35.06%
HSIC	9.3B	12.5B	0.39%	-2.78%	24.01	0.75	-0.61%	-18.83%
BIO	7.6B	2.6B	-17.82%	-26.90%	-23.72	2.94	-6.25%	-68.62%
XRAY	5.8B	3.9B	-13.74%	-32.04%	-61.76	1.47	0.23%	91.03%
AXNX	3.4B	387.1M	-0.59%	20.47%	-215.56	8.87	30.82%	65.57%
PDCO	2.3B	6.6B	-1.26%	-0.69%	11.98	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-6.92%	-14.34%	-1.85	0.4	7.94%	-1661.78%
ANIK	422.2M	169.3M	11.74%	12.93%	-5.49	2.49	7.49%	-244.90%
ANGO	235.9M	324.0M	-10.59%	-34.33%	-1.23	0.73	-3.19%	-337.41%
APYX	45.4M	52.3M	-10.27%	-60.90%	-2.43	0.87	17.61%	19.28%
AEMD	3.3M	3.7M	-25.00%	250.00%	-0.27	0.88	5.77%	8.23%

Masimo Corp News

Latest updates

Masimo Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-10.2%	493	549	479	455	565	617	549	565	304	328	307	305	299	295	278	301	270	248	229	230	232
Gross Profit	-8.0%	242	263	235	221	285	313	283	258	205	215	204	193	197	187	179	192	186	167	156	154	152
Operating Expenses	-5.0%	208	219	210	192	247	240	228	236	145	138	136	128	131	122	119	129	117	105	105	102	96.00
S&GA Expenses	0%	160	160	156	152	196	186	175	188	109	104	101	94.00	97.00	90.00	90.00	98.00	90.00	82.00	80.00	78.00	74.00
R&D Expenses	25.8%	48.00	38.00	47.00	40.00	51.00	54.00	53.00	48.00	36.00	33.00	35.00	34.00	35.00	32.00	29.00	31.00	27.00	23.00	24.00	24.00	21.00
EBITDA Margin	1.9%	0.09*	0.09*	0.13*	0.12*	0.14*	0.16*	0.16*	0.22*	0.24*	0.25*	0.25*	0.25*	0.25*	0.26*	0.26*	0.27*	0.28*	-	-	-	-
Interest Expenses	-	12.00	-	-	-	12.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Taxes	155.6%	6.00	-10.80	3.00	9.00	5.00	15.00	14.00	9.00	13.00	8.00	10.00	15.00	12.00	-4.00	12.00	8.00	8.00	11.00	5.00	11.00	11.00
Earnings Before Taxes	7.8%	25.00	23.00	14.00	25.00	26.00	56.00	52.00	27.00	59.00	77.00	68.00	65.00	65.00	67.00	61.00	64.00	72.00	64.00	54.00	56.00	60.00
EBT Margin	2.1%	0.04*	0.04*	0.06*	0.07*	0.07*	0.10*	0.12*	0.15*	0.22*	0.22*	0.22*	0.22*	0.22*	0.23*	0.24*	0.24*	0.25*	-	-	-	-
Net Income	-44.2%	19.00	34.00	11.00	16.00	21.00	41.00	38.00	18.00	47.00	68.00	58.00	50.00	53.00	71.00	49.00	56.00	64.00	53.00	49.00	45.00	49.00
Net Income Margin	0.6%	0.04*	0.04*	0.04*	0.05*	0.05*	0.07*	0.10*	0.13*	0.18*	0.19*	0.19*	0.19*	0.20*	0.21*	0.20*	0.21*	0.22*	-	-	-	-
Free Cashflow	-43.2%	38.00	66.00	-19.70	12.00	-8.10	-23.40	4.00	-7.10	3.00	93.00	75.00	21.00	50.00	52.00	32.00	49.00	5.00	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-2.8%	2,958	3,042	2,996	3,011	3,116	3,211	3,056	2,961	1,909	1,887	1,767	1,682	1,598	1,713	1,713	1,636	1,475	1,396	1,314	1,230	1,179
Current Assets	-5.4%	1,166	1,232	1,238	1,208	1,261	1,309	1,246	1,158	1,225	1,239	1,138	1,052	983	1,101	1,159	1,093	980	996	934	864	850
Cash Equivalents	0.6%	164	163	124	151	174	203	220	218	720	745	652	576	552	645	669	632	606	568	513	409	413
Inventory	-7.1%	506	545	585	543	504	501	495	449	213	201	202	207	216	216	205	155	116	116	110	99.00	93.00
Net PPE	-2.2%	415	424	415	410	402	403	372	371	300	273	275	275	275	273	267	263	253	220	209	203	167
Goodwill	-2.9%	396	408	400	411	422	445	446	435	318	100	101	102	102	103	80.00	79.00	54.00	22.00	22.00	22.00	22.00
Liabilities	-5.0%	1,593	1,677	1,720	1,703	1,785	1,872	1,804	1,758	327	337	299	290	270	305	298	291	221	228	206	190	174
Current Liabilities	-10.6%	504	564	579	572	583	630	587	552	254	268	228	220	197	234	233	228	157	172	150	136	121
Long Term Debt	-3.5%	841	872	910	889	898	942	951	922	-	-	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	872	910	889	898	942	951	922	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	0.0%	1,365	1,365	1,276	1,308	1,330	1,339	1,253	1,203	1,582	1,550	1,468	1,391	1,328	1,408	1,415	1,345	1,253	1,168	1,108	1,040	1,005
Retained Earnings	1.1%	1,815	1,796	1,762	1,751	1,736	1,714	1,674	1,636	1,617	1,571	1,503	1,445	1,395	1,341	1,271	1,221	1,165	1,100	1,048	998	954
Additional Paid-In Capital	1.5%	795	783	774	774	782	782	775	759	741	753	737	714	703	704	677	658	624	601	585	565	547
Shares Outstanding	0.5%	53.00	53.00	53.00	53.00	53.00	53.00	53.00	54.00	55.00	55.00	55.00	55.00	55.00	55.00	55.00	54.00	54.00	53.00	53.00	53.00	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02	-	-	-	-	-	-	-
Float	-	-	-	-	6,500	-	-	-	-	-	-	-	5,300	-	-	-	9,200	-	-	-	6,800	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-40.6%	46.00	77.00	-7.00	24.00	0.00	-6.60	10.00	2.00	23.00	98.00	82.00	26.00	59.00	65.00	40.00	64.00	42.00	70.00	51.00	58.00	42.00
Share Based Compensation	2.1%	10.00	9.00	-1.10	-8.60	7.00	6.00	14.00	17.00	11.00	11.00	13.00	8.00	13.00	6.00	12.00	13.00	11.00	10.00	11.00	11.00	7.00
Cashflow From Investing	25.3%	-18.90	-25.30	-22.40	-22.40	-11.10	-22.80	-7.70	-1,003	-23.90	-6.00	-14.30	-6.72	-10.47	-1.96	-10.19	-55.26	-15.39	-13.46	45.00	-41.34	-188
Cashflow From Financing	27.0%	-26.50	-36.30	19.00	-4.90	-35.20	-4.70	29.00	518	-22.20	4.00	10.00	3.00	-139	-93.25	6.00	21.00	11.00	-4.00	10.00	-21.27	6.00
Buy Backs	-	-	-	-	-	-	0.00	-	401	-	-	-	-0.02	129	110	-	0.00	0.00	10.00	0.00	28.00	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

MASI Income Statement

2024-03-30

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Income Statement [Abstract]
Revenue	$ 492.8	$ 565.0
Cost of goods sold	251.1	280.2
Gross profit	241.7	284.8
Operating expenses:
Selling, general and administrative	159.9	196.3
Research and development	47.8	50.5
Total operating expenses	207.7	246.8
Operating income	34.0	38.0
Non-operating loss	(9.1)	(11.8)
Income before provision for income taxes	24.9	26.2
Provision for income taxes	6.0	4.9
Net income	$ 18.9	$ 21.3
Net income per share:
Basic (in dollars per share)	$ 0.36	$ 0.40
Diluted (in dollars per share)	$ 0.35	$ 0.39
Weighted-average shares used in per share calculations:
Basic (in shares)	53.0	52.6
Diluted (in shares)	54.2	54.4

MASI Balance Sheet

2024-03-30

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023	Apr. 01, 2023
Current assets
Cash and cash equivalents	$ 157.6	$ 163.0	$ 174.1
Trade accounts receivable, net of allowance for credit losses of $4.7 million and $4.8 million at March 30, 2024 and December 30, 2023, respectively	330.7	355.5
Inventories	506.1	545.0
Assets held for sale	11.4		0.0
Other current assets	159.8	168.4
Total current assets	1,165.6	1,231.9
Lease receivable, non-current	70.3	71.4
Deferred costs and other contract assets	57.9	57.3
Property and equipment, net	415.0	424.4
Finite-lived intangible assets, net	413.2	419.9
Trademarks - (Note 9)	222.7	232.4
Goodwill	396.0	407.7
Deferred tax assets	107.1	107.2
Other non-current assets	109.9	89.3
Total assets	2,957.7	3,041.5
Current liabilities
Accounts payable	203.1	251.5
Accrued compensation	65.2	62.6
Deferred revenue and other contract liabilities, current	70.0	87.3
Other current liabilities	165.9	162.4
Total current liabilities	504.2	563.8
Long-term debt	841.4	871.7
Deferred tax liabilities	106.9	111.7
Other non-current liabilities	140.0	129.5
Total liabilities	1,592.5	1,676.7
Commitments and contingencies - (Note 24)
Stockholders’ equity
Preferred stock, $0.001 par value; 5.0 million shares authorized; 0 shares issued and outstanding	0.0	0.0
Common stock, $0.001 par value; 100.0 million shares authorized; 53.1 million and 52.8 million shares issued and outstanding at March 30, 2024 and December 30, 2023, respectively	0.1	0.1
Treasury stock, 19.5 million and 19.5 million shares at March 30, 2024 and December 30, 2023, respectively	(1,169.2)	(1,169.2)
Additional paid-in capital	794.9	783.4
Accumulated other comprehensive loss	(75.3)	(45.3)
Retained earnings	1,814.7	1,795.8
Total stockholders’ equity	1,365.2	1,364.8	$ 1,330.3
Total liabilities and stockholders’ equity	2,957.7	3,041.5
Customer relationships
Current assets
Finite-lived intangible assets, net	169.3	177.7
Acquired technologies
Current assets
Finite-lived intangible assets, net	119.9	129.4
Other intangible assets, net - (Note 9)
Current assets
Finite-lived intangible assets, net	$ 124.0	$ 112.8

About Masimo Corp

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

CEO	Mr. Joseph E. Kiani
WEBSITE	masimo.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	4000

Masimo Corp Frequently Asked Questions

What is the ticker symbol for Masimo Corp? What does MASI stand for in stocks?

MASI is the stock ticker symbol of Masimo Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Masimo Corp (MASI)?

As of Wed May 08 2024, market cap of Masimo Corp is 6.37 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MASI stock?

You can check MASI's fair value in chart for subscribers.

What is the fair value of MASI stock?

You can check MASI's fair value in chart for subscribers. The fair value of Masimo Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Masimo Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MASI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Masimo Corp a good stock to buy?

The fair value guage provides a quick view whether MASI is over valued or under valued. Whether Masimo Corp is cheap or expensive depends on the assumptions which impact Masimo Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MASI.

What is Masimo Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, MASI's PE ratio (Price to Earnings) is 80.58 and Price to Sales (PS) ratio is 3.23. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MASI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Masimo Corp's stock?

In the past 10 years, Masimo Corp has provided 0.185 (multiply by 100 for percentage) rate of return.